Skip to main content
SpringerLink
Log in

Organ-Selective Actions of Tamoxifen and Other Partial Antiestrogens

  • Conference paper
Organ-Selective Actions of Steroid Hormones

Part of the book series: Ernst Schering Research Foundation Workshop ((SCHERING FOUND,volume 16))

  • 72 Accesses

Abstract

A serious obstacle to the rational development of innovative approaches for preventing and/or treating osteoporosis is the idiopathic nature of postmenopausal bone loss. Estrogen deficiency is an important risk factor for osteoporosis. However, not all postmenopausal women develop osteoporotic fractures, indicating that estrogen deficiency alone is insufficient to fully account for the disorder. An increased understanding of the mechanisms whereby estrogen interacts with other factors to maintain bone balance is an important step in improving hormone replacement therapy in postmenopausal women.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Aitken JM, Hart DM, Lindsay R (1973) Estrogen replacement therapy for prevention of osteoporosis after oophorectomy. Br Med J 3: 515–518

    Article  PubMed  CAS  Google Scholar 

  • Arnold JS (1973) Amount and quality of trabecular bone in osteoporotic and vertebral fractures. Clin Endocrinol Metab 2: 221–238

    Article  PubMed  CAS  Google Scholar 

  • Beall PT, Misra LK, Young RL, Spjut HJ, Evans HJ, LeBlanc A (1984) Clomiphene protects against osteoporosis in the mature ovariectomized rat. Calcif Tissue Int 36: 123–125

    Article  PubMed  CAS  Google Scholar 

  • Bellido T, Girasole G, Passed G, Yu X-P, Mocharla H, Jilka RL, Notides A, Manolagas SC (1993) Demonstration of estrogen and vitamin D receptors in bone marrow-derived stromal cells: up-regulation of the estrogen receptor by 1,25-dihydroxyvitamin-D3. Endocrinology 133: 553–562

    Article  PubMed  CAS  Google Scholar 

  • Caputo CB, Meadows D, Raisz LG (1976) Failure of estrogens and androgens to inhibit bone resorption in tissue culture. Endocrinology 98: 1065–1068

    Article  PubMed  CAS  Google Scholar 

  • Chen TL, Feldman D (1978) Distinction between alpha-fetoprotein and intracellular estrogen receptors: evidence against the presence of estradiol receptors in rat bone. Endocrinology 102: 236–244

    Article  PubMed  CAS  Google Scholar 

  • Chow J, Tobias JH, Colston KW, Chambers TJ (1992) Estrogen maintains trabecular bone volume in rats not only by suppression of bone resorption but also by stimulation of bone formation. J Clin Invest 89: 74–78

    Article  PubMed  CAS  Google Scholar 

  • Colletti RB, Roberts JD, Devlin JT, Copeland KC (1989) Effect of tamoxifen on plasma insulin-like growth factor I in patients with breast cancer. Cancer Res 49: 1882–1884

    PubMed  CAS  Google Scholar 

  • Cummings SR, Kelsey 7L, Nevitt MC, O’Dowd KJ (1985) Epidemiology of osteoporosis and osteoporotic fractures. Epidemiol Rev 7: 178–208

    CAS  Google Scholar 

  • Dnistrian AM, Greenberg EJ, Dillon HJ, Hakes TB, Fracchia AA, Schwartz MK (1985) Chemohormonal therapy and endocrine function in breast cancer patients. Cancer 56: 63–70

    Article  PubMed  CAS  Google Scholar 

  • Dukes M, Chester R, Yarwood L, Wakeling AE (1994) Effects of non-steroidal pure antiestrogen, ZM 189,154, on oestrogen target organs of the rat including bones. J Endocrinol 141: 335–341

    Article  PubMed  CAS  Google Scholar 

  • Eastell R, Delmas PD, Hodgson SF, Eriksen EF, Mann KG, Riggs BL (1988) Bone formation rate in older normal women: concurrent assessment with bone histomorphometry, calcium kinetics, and biochemical markers. J Clin Endocrinol Metab 67: 741–748

    Article  PubMed  CAS  Google Scholar 

  • Eriksen EF, Colvard DS, Berg NJ, Graham ML, Mann KG, Spelsberg TC, Riggs BL (1988) Evidence of estrogen receptors in normal human osteoblast-like cells. Science 241: 84–86

    Article  PubMed  CAS  Google Scholar 

  • Evans GL, Bryant HU, Magee D, Sato M, Turner RT (1994) Raloxifene is a tissue specific estrogen agonist which prevents osteopenia in ovariectomized rats. Endocrinology 134: 2283–2288

    Article  PubMed  CAS  Google Scholar 

  • Feldman S, Minne HW, Parviz S, Pfeifer M, Lempert VG, Bauss F, Zeigler R (1989) Antiestrogen and antiandrogen administration reduce bone mass in the rat. J Bone Miner Res 7: 245–254

    Article  Google Scholar 

  • Fentiman CM, Rodin A, Murby B, Fogelman I (1989) Bone mineral content of women receiving tamoxifen for mastalgia. Br J Cancer 60: 262–264

    Article  PubMed  CAS  Google Scholar 

  • Frenay M, Milano G, Formento JL, Francoual M, Moll JL, Namer M (1991) Oestrogen and progesterone receptor status in bone biopsy specimens from patients with breast cancer. Eur J Cancer 27: 115–118

    Article  PubMed  CAS  Google Scholar 

  • Frost HM (1963) Dynamics of bone remodeling. In: Frost JM (ed) Bone biodynamics. Little Brown, Boston, pp 1–168

    Google Scholar 

  • Gallagher A, Chambers TJ, Tobias JH (1993) The estrogen antagonist ICI 182,780 reduces cancellous bone volume in female rats. Endocrinology 133: 2787–2791

    Article  PubMed  CAS  Google Scholar 

  • Garn SM, Rohmann CG, Wagner B (1967) Bone loss as a general phenomenon in man. Fed Proc 26: 1729–1736

    PubMed  CAS  Google Scholar 

  • Genant HK, Baylink DJ, Gallagher JC (1989) Estrogens in the prevention of osteoporosis in postmenopausal women. Am J Obstet Gynecol 161: 18421846

    Google Scholar 

  • Gotfredson A, Christiansen C, Palshof T (1984) The effect of tamoxifen on bone mineral content in premenopausal women with breast cancer. Cancer 53: 853–857

    Article  Google Scholar 

  • Hazzard WR (1989) Estrogen replacement and cardiovascular disease: serum lipids and blood pressure effects. Am J Obstet Gynecol 161: 1847–1853

    PubMed  CAS  Google Scholar 

  • Henderson BE (1989) The cancer question: an overview of recent epidemiologic and retrospective data Am J Obstet Gynecol 161: 1859–1864

    CAS  Google Scholar 

  • Jordan VC (1982) Metabolites of tamoxifen in animals and man: identification, pharmacology and significance. Breast Cancer Res Treat 2: 123–138

    Article  PubMed  CAS  Google Scholar 

  • Jordan VC, Murphy CS (1990) Endocrine pharmacology of antiestrogens as antitumor agents. Endocr Rev 11: 578–610

    Article  PubMed  CAS  Google Scholar 

  • Jordan VC, Fritz NF, Tormey DC (1987a) Long-term adjuvant therapy with tamoxifen: effect on sex hormone binding globulin and antithrombin III. Cancer Res 47: 4517–4519

    PubMed  CAS  Google Scholar 

  • Jordan VC, Phelps E, Lindgren JV (1987b) Effects of antiestrogens on bone in castrated and intact female rats. Breast Cancer Res Treat 10: 31–35

    Article  PubMed  CAS  Google Scholar 

  • Kalu DN, Liu CC, Hardin RR, Hollis BW (1989) The aged rat model of ovarian hormone deficiency bone loss. Endocrinology 124: 7–16

    Article  PubMed  CAS  Google Scholar 

  • Kalu DN, Salerno E, Liu CC, Echon R, Ray M, Garza-Zapata M (1991) A comparative study of the actions of tamoxifen, estrogen, and progesterone in the ovariectomized rat. Bone Miner 15: 109–123

    Article  PubMed  CAS  Google Scholar 

  • Komm BS, Terpening CM, Benz DJ, Graeme KA, Gallegos A, Kore M, Greene GL, O’Malley BW, Haussier MR (1988) Estrogen binding, receptor mRNA and biologic response in osteoblast-like osteosarcoma cells. Science 241: 81–84

    Article  PubMed  CAS  Google Scholar 

  • Kristensen B, Moridsen HT, Holmegaard SN, Transbol I (1989) Amelioration of postmenopausal primary hyperparathyroidism during adjuvant tamoxifen for breast cancer. Cancer 64: 1965–1967

    Article  PubMed  CAS  Google Scholar 

  • Love RR, Mazeus RB, Tormay DC, Barden HS, Newcomb PA, Hordan VC (1988) Bone mineral density in women with breast cancer treated with adjuvant tamoxifen for two years. Breast Cancer Res Treatment 12: 297–301

    Article  CAS  Google Scholar 

  • Mack TM, Ross RK (1989) Risks and benefits of long-term treatment with estrogens. Schweiz Med Wochenschr 119: 1811–1820

    PubMed  CAS  Google Scholar 

  • Manni A, Pearson OH (1980) Antiestrogen-induced remission in premenopausal women with stage IV breast cancer: effects on ovarian function. Cancer Treat Rep 64: 779–785

    PubMed  CAS  Google Scholar 

  • Martin PM, Berthois Y, Jensen EV (1988) Binding of antiestrogens exposes an occult antigenic determinant in the human estrogen receptor. Proc Natl Acad Sci USA 85: 2533–2537

    Article  PubMed  CAS  Google Scholar 

  • Miller SC, Wronski TJ (1993) Long-term osteopenic changes in cancellous bone structure in ovariectomized rats. Anat Rec 236: 433–441

    Article  PubMed  CAS  Google Scholar 

  • Moon L, Wakley GK, Turner RT (1991) Dose and ovary dependent effects of tamoxifen on bone balance in tibia of maturing rats. Endocrinology 129: 1568–1574

    Article  PubMed  CAS  Google Scholar 

  • Oursler M, Osdoby P, Pyfferoen J, Riggs BL, Spelsberg TC (1991) Avian os- teoclasts as estrogen target cells. Proc Natl Acad Sci USA 88: 6613–6617

    Article  PubMed  CAS  Google Scholar 

  • Riggs BL, Wahner HW, Dunn WL, Mazess RB, Offord KP, Melton LJ (1981) Differential changes in bone mineral density of the appendicular and axial skeleton with aging. J Clin Invest 67: 328–335

    Article  PubMed  CAS  Google Scholar 

  • Riggs BL, Wahner HW, Melton LJ III, Richelson LS, Judd HL, Offord KP (1986) Rates of bone loss in the appendicular and axial skeletons of women. J Clin Invest 77: 1487–1491

    Article  PubMed  CAS  Google Scholar 

  • Robinson SP, Langan-Fahey SM, Johnson DA, Jordan VC (1991) Metabolites, pharmacodynamics and pharmacokinetics of tamoxifen in rats and mice compared to the breast cancer patient. Drug Metab Dispos 19: 36–43

    PubMed  CAS  Google Scholar 

  • Rose DP, Davis TE (1980) Effects of adjuvant chemohormonal therapy on the ovarian and adrenal function of breast cancer patients. Cancer Res 40: 4043–4047

    PubMed  CAS  Google Scholar 

  • Sakai F, Cheix F, Clavel M, Colon J, Mayer M, Pommatau E, Saez S (1978) Increases in steroid binding globulins induced by tamoxifen in patients with carcinoma of the breast. J Endocrinol 76: 219–226

    Article  PubMed  CAS  Google Scholar 

  • Santen RJ, Manni A, Harvey H, Redmond C (1990) Endocrine treatment of breast cancer in women. Endocr Rev 11: 221–265

    Article  PubMed  CAS  Google Scholar 

  • Sherman BM, Chapler FK, Crickard K, Wycoff D (1979) Endocrine consequences of continuous antiestrogen therapy with tamoxifen in premenopausal women. J Clin Invest 64: 398–404

    Article  PubMed  CAS  Google Scholar 

  • Somjen D, Weisman Y, Harrel A, Berger E, Kaye AM (1989) Direct and sex-specific stimulation by sex steroids of creatine kinase activity and DNA synthesis in rat bone. Proc Natl Acad Sci USA 86: 3361–3365

    Article  PubMed  CAS  Google Scholar 

  • Stewart PJ, Stern PH (1986) Effect of the antiestrogens tamoxifen and clomiphene on bone resorption in vitro. Endocrinology 118: 125–131

    Article  PubMed  CAS  Google Scholar 

  • Szamel I, Vincze B, Hindy I, Herman I, Borvendeg J, Eckhardt S (1986) Hormonal changes during a prolonged tamoxifen treatment in patients with advanced breast cancer. Oncology 43: 7–11

    Article  PubMed  CAS  Google Scholar 

  • Tajima C, Fukushima T (1983) Endocrine profiles in tamoxifen-induced ovulatory cycles. Fertil Steril 40: 23–30

    PubMed  CAS  Google Scholar 

  • Tate AC, Greene GL, DeSombre ER, Jensen EV, Jordan VC (1984a) Differences between estrogen and antiestrogen-estrogen receptor complexes from human breast tumors identified with an antibody raised against the estrogen receptor. Cancer Res 44: 1012–1018

    PubMed  CAS  Google Scholar 

  • Tate AC, Lieberman ME, Jordan VC (1984b) The inhibition of prolactin synthesis in GH3 rat pituitary tumor cells by monohydroxytamoxifen is associated with changes in the properties of the estrogen receptor. J Steroid Biochem 20: 391–395

    Article  PubMed  CAS  Google Scholar 

  • Turner RT, Vandersteenhoven JJ, Bell NH (1987a) The effects of ovariectomy and 17 beta estradiol on cortical bone histomorphometry in growing rats. J Bone Miner Res 2: 115–122

    Article  PubMed  CAS  Google Scholar 

  • Turner RT, Wakley GK, Hannon KS, Bell NH (1987b) Tamoxifen prevents the altered bone turnover resulting from ovarian hormone deficiency. J Bone Miner Res 2: 449–456

    Article  PubMed  CAS  Google Scholar 

  • Turner RT, Wakley GK, Hannon KS, Bell NH (1988) Tamoxifen inhibits osteoclast mediated resorption of trabecular bone in ovarian hormone deficient rats. Endocrinology 122: 1146–1150

    Article  PubMed  CAS  Google Scholar 

  • Turner RT, Hannon KS, Demers L, Buchanan J, Bell NH (1989) Differential effects of gonadal function on bone histomorphometry in male and female rats. J Bone Miner Res 4: 557–563

    Article  PubMed  CAS  Google Scholar 

  • Turner RT, Colvard DS, Spelsberg TC (1990) Estrogen inhibition of periosteal bone formation in rat long bones: down regulation of gene expression for bone matrix proteins. Endocrinology 127: 1346–1351

    Article  PubMed  CAS  Google Scholar 

  • Turner RT, Bell NH, Gay CV (1993a) Estrogen receptors and bone: evidence that estrogen-binding sites are present in bone cells and mediate medullary bone formation in Japanese quail. Poultry Sci 72: 728–740

    Article  CAS  Google Scholar 

  • Turner RT, Evans GL, Wakley GK (1993b) The mechanism of action of estrogen on cancellous bone balance in tibial of ovariectomized growing rats: inhibition of indices of formation and resorption. J Bone Miner Res 8: 359–366

    Article  PubMed  CAS  Google Scholar 

  • Turner RT, Evans GL, Wakley GK (1994a) Reduced chondroclast differentiation results in increased cancellous bone volume in estrogen-treated growing rats. Endocrinology 134: 461–466

    Article  PubMed  CAS  Google Scholar 

  • Turner RT, Riggs BL, Spelsberg TC (1994b) Skeletal effects of estrogen. Endocr Rev 15: 275–300

    PubMed  CAS  Google Scholar 

  • Tzukerman MT, Esty A, Santiso-Mere D, Danielian P, Parker MG, Stein RB, Pike JW, McDonnell DP (1994) Human estrogen receptor transactivational capacity is determined by both cellular and promotor context and mediated by two functionally distinct intramolecular regions. Mol Endocrinol 8: 21–30

    Article  PubMed  CAS  Google Scholar 

  • Wakley GK, Baum RL, Hannon KS, Turner RT (1988) Tamoxifen treatment reduces osteopenia induced by immobilization in the rat. Calcif Tissue Int 43: 383–388

    Article  PubMed  CAS  Google Scholar 

  • Wakley GK, Shutte DE, Hannon KS, Turner RT (1991) The effects of castration and androgen replacement therapy on bone: a histomorphometric study in the rat. J Bone Miner Res 6: 325–330

    Article  PubMed  CAS  Google Scholar 

  • Waters DJ, Caywood DD, Turner RT (1991) Effect of tamoxifen citrate on canine immobilization (disuse) osteoporosis. Vet Surg 20: 392–396

    Article  PubMed  CAS  Google Scholar 

  • Webster NJCT, Green S, Jin SR, Chambon P (1988) The hormone-binding domains of the estrogen and glucocorticoid receptors contain an inducible transcription activation function. Cell 54: 199–207

    Article  PubMed  CAS  Google Scholar 

  • Westerlind KC, Evans GL, Wronski TJ, Bell NH, Turner RT (1995) Estrogen regulates the rate of bone turnover but bone balance is determined by mechanical strain. Presented at the XIIth international conference on calcium regulating hormones, Melbourne, Australia, 14–19 February

    Google Scholar 

  • Westerlind KC, Wakley GK, Evans GL, Turner RT (1993) Estrogen does not increase bone formation in growing rats. Endocrinology 133: 2924–2934

    Article  PubMed  CAS  Google Scholar 

  • Williams DC, Paul DC, Black LJ (1991) Effects of estrogen and tamoxifen on serum osteocalcin levels in ovariectomized rats. Bone Miner 14: 205–220

    Article  PubMed  CAS  Google Scholar 

  • Wronski TJ, Cintron M, Doherty SL, Dann LM (1988) Estrogen treatment prevents osteopenia and depresses bone turnover in ovariectomized rats. Endocrinology 123: 681–686

    Article  PubMed  CAS  Google Scholar 

  • Wronski TJ, Lowry PL, Walsh CC, Ignaszewski LA (1985) Skeletal alterations in ovariectomized rats. Calcif Tissue Int 37: 324–328

    Article  PubMed  CAS  Google Scholar 

  • Wronski TJ, Walsh CC, Ignaszewski LA (1986) Histological evidence for osteopenia and increased bone turnover in ovariectomized rats. Bone 7: 119123

    Google Scholar 

  • Yamamoto TT, Rodan GA (1990) Direct effects of 1713-estradiol on trabecular bone in ovariectomized rats. Proc Natl Acad Sci USA 87: 2172–2176

    Article  Google Scholar 

  • Yoshioka T, Sato B, Matsumoto K, Ono K (1980) Steroid receptors in osteoblasts. Clin Orthop 148: 297–303

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. R. T. Turner
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Obstetrics and Gynaecology, Centre for Reproductive Biology, University of Edinburgh, 37 Chalmers Street, EH3 9EW, Edinburgh, Scotland

    D. T. Baird

  2. German Cancer Research Center, Molecular Biology of the Cell I, Im Neuenheimer Feld 280, 69120, Heidelberg, Germany

    G. Schütz

  3. Research Laboratories of Schering AG, 13342, Berlin, Germany

    R. Krattenmacher

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Turner, R.T. (1995). Organ-Selective Actions of Tamoxifen and Other Partial Antiestrogens. In: Baird, D.T., Schütz, G., Krattenmacher, R. (eds) Organ-Selective Actions of Steroid Hormones. Ernst Schering Research Foundation Workshop, vol 16. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-09153-1_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-09153-1_4

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-09155-5

  • Online ISBN: 978-3-662-09153-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation